IFN-α treatment resulted in moderate to high numbers of CD4+ cells infiltrating close to tumor cells in 12 out of 26 metastases compared to 1 out of 10 metastases from untreated patients [51]. The gene discussed is IFNA1; the disease is neoplasm.